Eben Crawford

Eben Crawford is a skilled professional in the biotechnology and bioengineering sectors with extensive experience in process development and business operations. Currently serving as Senior Business Operation Specialist at Ultragenyx since September 2022, responsibilities include expanding the Gene Therapy COGS model and improving data practices. Prior to Ultragenyx, Eben held various roles at Chromatan, Inc. from October 2018 to September 2022, including R&D Associate Director, where work involved the development of next-generation CCTC systems for therapeutic applications, and R&D Manager, focusing on purification strategies. Experience at Celldex Therapeutics from December 2013 to September 2018 encompassed developing purification schemes for monoclonal antibodies and optimizing laboratory operations. Educational credentials include a Bachelor of Science in Bioengineering from the University of Massachusetts Dartmouth.